Tips

美迪西匯總整理了12月生物醫(yī)藥行業(yè)會(huì)議供參考交流。同時(shí)，我們將計(jì)劃參與海內(nèi)外5場會(huì)議：

SLAS-ELRIG Networking Event

Ready to Meet Medicilon at SLAS-ELRIG Networking Event?

Revolutionary Adhesion: Unveiling the Power of Molecular Glues in Medicine, Science and Beyond!

We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities.

Proteolysis targeting chimeras (PROTACs) offer a fast and reversible chemical knock-down approach to control protein function. PROTAC technology takes advantage of a moiety of targeted protein and a moiety of recognizing E3 ubiquitin ligase and produces a hybrid molecule to specifically knock down a targeted protein.

Medicilon provides PROTAC drug discovery, CMC research (API + formulation), pharmacodynamics research, PK study, safety evaluation and other services. Medicilon’s PROTAC drug discovery technology platform covers the currently popular target protein ligands. We have established a linker system with an extensive collection of bifunctional linkers. Together with our expanding E3 ubiquitin ligase binder library, we can efficiently synthesize a substantial amount of highly active PROTAC bispecific small molecules, which would have the potential to significantly facilitate the drug discovery and development process. As of the end of June 2023, Medicilon has successfully assisted in the clinical approval of 5 PROTAC drugs and has 20+ PROTAC projects under development.

Date: Tuesday 5 December 2023 from 10:00 -18:00

Location: 1 Wimpole Street, London, W1G 0AE

Genesis 2023

Join Medicilon at Genesis 2023!

Fostering Innovation, Investment, and Deal-making at Genesis 2023.

For over two decades, the annual Genesis conference has brought key Life Science opinion leaders and stakeholders together to debate key trends, instigate deals and generate a vision of the future.

By facilitating critical networking, and sharing the latest insights in the Life Sciences industry, One Nucleus' Genesis 2023 & Genesis Fringe Seminars can help you and your organization along your journey to success. 300 delegates from across the industry attend Genesis, and this year is expected to achieve the same on 5-8 December in Central London. Between the insightful keynote sessions are valuable breaks where you can continue the exciting stimulating discussions, and meet contacts old and new.

Dr. Jing Deng, our VP of Pharmacology, Pharmacodynamics and Biology Department, will give a great presentation titled "New technology platforms in preclinical research" in Genesis Fringe Seminar on December 5th, 2023, 18:00-21:00 pm.

InnoXBio首屆大灣區(qū)細(xì)胞基因治療發(fā)展論壇

InnoXBio生物醫(yī)藥產(chǎn)業(yè)生態(tài)圈大會(huì)暨首屆大灣區(qū)細(xì)胞基因治療發(fā)展論壇定于2023年12月7-8日，在廣州知識(shí)城國際會(huì)展中心召開，大會(huì)將邀請(qǐng)CGT產(chǎn)業(yè)上下游行業(yè)專家，以主題演講、圓桌討論、產(chǎn)品展示等形式分享行業(yè)成果與前沿動(dòng)態(tài)，把握產(chǎn)業(yè)發(fā)展脈搏，攜手各方，共筑產(chǎn)業(yè)興！

Mediclon Boston Opening

Celebrate Mediclon Boston Opening！

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D service for pharmaceutical enterprises and scientific research institutions around the world. We are excited to invite you to the Medicilon Boston Site Opening Reception for a great time of lunch, networking, and discussion.

The theme of this event is to share hopes and bright future of biomedicine. With the opening its Boston site, Medicilon is committed to working ever closely with our partners in their pursuit of finding cures for patients in need.

Date: December 9th, 2023 (Saturday)

Time:11:00 am - 2:00 pm

Venue: Medicilon Boston Site (50 Soldiers Field Place, Boston, MA 02135)

ASH 2023

We look forward to meeting you at ASH 2023!

With more than 18,000 members from nearly 100 countries, ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases. Fostering high-quality, equitable care, transformative research, and innovative education to improve the lives of patients with blood and bone marrow disorders.

Medicilon team are present throughout the conference.

Medicilon translational medicine platform is committed to providing global partners with comprehensive biomarker discovery, target integrated solutions for point-of-care verification, companion diagnostic development, and commercial testing.

We look forward to welcoming you in San Diego!

Date: December 9-12, 2023

Location: San Diego

2023深圳生物醫(yī)藥產(chǎn)業(yè)創(chuàng)新與發(fā)展高峰論壇會(huì)

由深圳市坪山區(qū)科技創(chuàng)新局指導(dǎo)，南方科技大學(xué)坪山生物醫(yī)藥研究院和化學(xué)化工專業(yè)委員會(huì)聯(lián)合主辦，深圳市坪山區(qū)小分子新藥創(chuàng)聯(lián)協(xié)會(huì)、藥渡經(jīng)緯信息科技(北京)有限公司、銀星坪山生命健康科技園聯(lián)合承辦，深圳市坪山區(qū)產(chǎn)業(yè)資本投資有限公司、貝殼學(xué)社、深圳市生命科學(xué)與生物技術(shù)協(xié)會(huì)、深圳市坪山區(qū)高層次人才協(xié)會(huì)、深圳市華先醫(yī)藥科技有限公司、深圳艾欣達(dá)偉醫(yī)藥科技有限公司、深圳安泰維生物醫(yī)藥有限公司、深圳格林凱特醫(yī)藥技術(shù)有限公司、化學(xué)加聯(lián)合協(xié)辦的“2023深圳生物醫(yī)藥產(chǎn)業(yè)創(chuàng)新發(fā)展高峰論壇暨化學(xué)化工專業(yè)委員會(huì)年會(huì)”，擬定于2023年12月10日在深圳市坪山銀星生命健康產(chǎn)業(yè)園舉辦。

2023深圳灣實(shí)驗(yàn)室轉(zhuǎn)化醫(yī)學(xué)高峰論壇

本次會(huì)議以“醫(yī)藥創(chuàng)新加速、轉(zhuǎn)化助力共贏”為主題，匯聚國內(nèi)外有實(shí)戰(zhàn)轉(zhuǎn)化經(jīng)驗(yàn)的科研院所、創(chuàng)新藥企、生物科技公司、投資公司、CXO等生態(tài)群體，助力科研機(jī)構(gòu)醫(yī)藥創(chuàng)新與轉(zhuǎn)化，致力于打造中國醫(yī)藥創(chuàng)新和轉(zhuǎn)化領(lǐng)域頂尖的行業(yè)盛會(huì)。

參會(huì)嘉賓將就“新型科研機(jī)構(gòu)如何進(jìn)行轉(zhuǎn)化”“醫(yī)藥資本市場對(duì)創(chuàng)新藥開發(fā)方向”“創(chuàng)新藥源頭開發(fā)策略”以及“科研機(jī)構(gòu)如何同藥企進(jìn)行更好的合作”等問題共同思考、分享實(shí)踐、探尋方法。

2023首屆長三角生物醫(yī)藥產(chǎn)業(yè)大會(huì)

由長三角企業(yè)家聯(lián)盟、浙江省工商業(yè)聯(lián)合會(huì)指導(dǎo)，杭州市濱江區(qū)人民政府、長三角數(shù)據(jù)驅(qū)動(dòng)創(chuàng)新生物醫(yī)藥產(chǎn)業(yè)鏈聯(lián)盟、中國生物醫(yī)藥產(chǎn)業(yè)鏈創(chuàng)新轉(zhuǎn)化聯(lián)合體主辦，火石數(shù)鏈、貝達(dá)藥業(yè)、南京生物醫(yī)藥創(chuàng)新轉(zhuǎn)化中心、藥咖薈承辦的“長三角生物醫(yī)藥產(chǎn)業(yè)大會(huì)”將于2023年12月14-16日在杭州召開。

本次大會(huì)以“數(shù)智時(shí)代 醫(yī)藥生存與創(chuàng)新”為主題，整合長三角地區(qū)IT+BT資源，交流探討數(shù)字技術(shù)賦能生物醫(yī)藥產(chǎn)業(yè)數(shù)字化轉(zhuǎn)型新路徑與新經(jīng)驗(yàn)，推進(jìn)產(chǎn)業(yè)大數(shù)據(jù)及數(shù)字技術(shù)在藥物發(fā)現(xiàn)、設(shè)計(jì)、研發(fā)、臨床研究、質(zhì)量檢測、全鏈條管理等數(shù)字化場景應(yīng)用創(chuàng)新。通過數(shù)據(jù)驅(qū)動(dòng)+產(chǎn)業(yè)互聯(lián)，把產(chǎn)業(yè)數(shù)字化治理與藥械企業(yè)創(chuàng)新生態(tài)構(gòu)建相結(jié)合，以數(shù)據(jù)流帶動(dòng)業(yè)務(wù)流，推動(dòng)數(shù)據(jù)要素價(jià)值化，醫(yī)藥營銷合規(guī)化，打造服務(wù)全國的產(chǎn)業(yè)服務(wù)交流平臺(tái)，實(shí)現(xiàn)數(shù)據(jù)驅(qū)動(dòng)全要素生產(chǎn)率和醫(yī)藥產(chǎn)業(yè)資源配置效率的提升，助力長三角數(shù)字化發(fā)展之路走深走實(shí)，共筑產(chǎn)業(yè)新生態(tài)。

第二屆中國?寧波生物醫(yī)藥產(chǎn)業(yè)發(fā)展大會(huì)

生物醫(yī)藥作為中國七大戰(zhàn)略性新興產(chǎn)業(yè)之一，是健康中國建設(shè)的重要基礎(chǔ)，也是寧波市重點(diǎn)聚焦的戰(zhàn)略性新興產(chǎn)業(yè)。為深入推進(jìn)生物醫(yī)藥產(chǎn)業(yè)高質(zhì)量快速發(fā)展，優(yōu)化全球臨床開發(fā)和跨境合作，促進(jìn)技術(shù)成果推介和供需對(duì)接，“第二屆中國?寧波生物醫(yī)藥產(chǎn)業(yè)發(fā)展大會(huì)”暨“第三屆新藥創(chuàng)業(yè)在前灣項(xiàng)目路演&投融資洽談會(huì)”將于2023年12月15-17日在前灣新區(qū)寧波杭州灣凱悅酒店舉辦。

會(huì)議將圍繞創(chuàng)新藥研發(fā)、細(xì)胞基因療法、AI與合成生物學(xué)、小核酸藥物研發(fā)、中藥現(xiàn)代化等專題進(jìn)行探討交流，深度融合行業(yè)資源和產(chǎn)業(yè)資本，共同推進(jìn)生物醫(yī)藥產(chǎn)業(yè)的蓬勃發(fā)展。誠摯地邀請(qǐng)您撥冗出席本次盛會(huì)！

2023創(chuàng)新藥華北峰會(huì)

作為中國生物醫(yī)藥四大聚集地之一，京津冀地區(qū)已成為我國生物醫(yī)藥產(chǎn)業(yè)發(fā)展重要集聚地之一，初步形成了以北京為核心、天津和河北互補(bǔ)協(xié)作的產(chǎn)業(yè)協(xié)同發(fā)展格局。其中北京生物醫(yī)藥產(chǎn)業(yè)創(chuàng)新優(yōu)勢突出，初步形成了“一南一北、各具特色”的空間布局。“南”包括以亦莊和大興生物醫(yī)藥基地為核心的高端產(chǎn)業(yè)基地，“北”包括以中關(guān)村生命科學(xué)園為核心的研發(fā)創(chuàng)新中心。

其中RNA療法產(chǎn)業(yè)華北論壇將聚焦RNA療法突破，關(guān)注小核酸藥物開發(fā)、mRNA新型傳染病疫苗、mRNA新型癌癥疫苗等產(chǎn)品的開發(fā)，大會(huì)將于12月27日-28日在北京舉辦，基于前三屆RNA療法與新型疫苗產(chǎn)業(yè)峰會(huì)，本次峰會(huì)將吸引超過1300人次參會(huì)嘉賓。

marketing@medicilon.com.cn
微信或郵件聯(lián)系我們